Concentration of VCAM-1 in Serum and Urine in Henoch-Schonlein Purpura Nephritis and its Clinical Significance
Rui-Xia Lin
Abstract
Rui-Xia Lin
Abstract
Objective:To explore the concentration of soluble vascular cellular adhesion molecule-1(sVCAM-1) in serum and urine in children with Henoch-Schonlein purpura nephritis(HSPN) and explore its clinical significance.Methods:There were 50 patients with HSP in the study.They were divided into two groups according to their renal lesions:30 cases with HSPN and 20 cases without HSPN(as NO-HSPN group).The control group included 20 healthy children.The concentration of sVCAM-1 in serum and urine of all children were detected by enzyme-linked immunosorbent assay(ELISA).Then we compared the concentrations in every group and analyzed the relationship between the concentrations of sVCAM-1 and the main clinical markers(including 24 hours urinary protein and urinary erythrocyte).Results:The serum concentrations of sVCAM-1 in HSPN group(809.79±173.32)ng/ml and NO-HSPN group(623.44±67.27)ng/ml were both significantly higher than those in the control group(494.79±59.84)ng/ml(P0.01).The serum concentration of sVCAM-1 in HSPN group was significantly higher than that in NO-HSPN group(P0.01).The urinary concentration of sVCAM-1 in HSPN group were significantly higher than those in NO-HSPN group(P0.01) and the control group(P0.01),but there was no significant difference between the NO-HSPN group and the control group(P0.05).The concentration of VCAM-1 in the proteinuria group was significantly higher than that in the no-proteinuria group(P0.01).The concentration of VCAM-1 in the nephropathy proteinuria group was significantly higher than those in the proteinuria group(P0.05) and the no-proteinuria group(P0.01).The serum concentration of sVCAM-1 in the gross hematuria group was significantly higher than that in the no-hematuria group(P0.01),but was not significantly different from that in the microscopic hematuria group(P0.05).The serum concentration of sVCAM-1 in the microscopic hematuria group was higher than that in the no-hematuria group(P0.01) too.The urinary concentrations of sVCAM-1 were different in the groups with different levels of hematuria,because sVCAM-1 levels were significantly higher in the gross hematuria group and the microscopic hematuria group than that in the no-hematuria group(P0.05).But it was not significantly different between the microscopic hematuria group and the gross hematuria group(P0.05).There was a significantly positive correlation between the concentration of sVCAM-1 both in serum and in urine and the level of 24 hours urinary protein and urinary erythrocyte too(P0.01).Conclusion:It suggest that VCAM-1 is involved in the course of the onset and the development of HSPN.The sVCAM-1 in urine is worthy of detection for monitoring the renal lesions.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To explore the concentration of soluble vascular cellular adhesion molecule-1(sVCAM-1) in serum and urine in children with Henoch-Schonlein purpura nephritis(HSPN) and explore its clinical significance.Methods:There were 50 patients with HSP in the study.They were divided into two groups according to their renal lesions:30 cases with HSPN and 20 cases without HSPN(as NO-HSPN group).The control group included 20 healthy children.The concentration of sVCAM-1 in serum and urine of all children were detected by enzyme-linked immunosorbent assay(ELISA).Then we compared the concentrations in every group and analyzed the relationship between the concentrations of sVCAM-1 and the main clinical markers(including 24 hours urinary protein and urinary erythrocyte).Results:The serum concentrations of sVCAM-1 in HSPN group(809.79±173.32)ng/ml and NO-HSPN group(623.44±67.27)ng/ml were both significantly higher than those in the control group(494.79±59.84)ng/ml(P0.01).The serum concentration of sVCAM-1 in HSPN group was significantly higher than that in NO-HSPN group(P0.01).The urinary concentration of sVCAM-1 in HSPN group were significantly higher than those in NO-HSPN group(P0.01) and the control group(P0.01),but there was no significant difference between the NO-HSPN group and the control group(P0.05).The concentration of VCAM-1 in the proteinuria group was significantly higher than that in the no-proteinuria group(P0.01).The concentration of VCAM-1 in the nephropathy proteinuria group was significantly higher than those in the proteinuria group(P0.05) and the no-proteinuria group(P0.01).The serum concentration of sVCAM-1 in the gross hematuria group was significantly higher than that in the no-hematuria group(P0.01),but was not significantly different from that in the microscopic hematuria group(P0.05).The serum concentration of sVCAM-1 in the microscopic hematuria group was higher than that in the no-hematuria group(P0.01) too.The urinary concentrations of sVCAM-1 were different in the groups with different levels of hematuria,because sVCAM-1 levels were significantly higher in the gross hematuria group and the microscopic hematuria group than that in the no-hematuria group(P0.05).But it was not significantly different between the microscopic hematuria group and the gross hematuria group(P0.05).There was a significantly positive correlation between the concentration of sVCAM-1 both in serum and in urine and the level of 24 hours urinary protein and urinary erythrocyte too(P0.01).Conclusion:It suggest that VCAM-1 is involved in the course of the onset and the development of HSPN.The sVCAM-1 in urine is worthy of detection for monitoring the renal lesions.
Key concepts: Proteinuria, Nephritis, Urine, Purpura (gastropod), Medicine, Internal medicine, Urinary system, Gastroenterology